Multiple intracellular proteins

Multiple intracellular proteins is a collective designation used in pharmacology and bioinformatics to describe a scenario where a chemical agent interacts with a wide array of protein targets within a cell rather than a single, specific molecular entity (ChEMBL, 2024). This term is typically applied to highly reactive compounds, such as non-specific antiseptics, cross-linking fixatives, or heavy metal salts, which exert their biological effects by binding to or modifying various functional groups across numerous protein families (PubChem, 2024). Because these interactions are not localized to a single pathway, the resulting effect is often the sum of widespread cellular disruption, affecting metabolic enzymes, structural proteins, and signaling molecules simultaneously (NCBI, 2024). In a therapeutic context, agents that target multiple intracellular proteins often face significant challenges due to a lack of molecular specificity, which frequently leads to a narrow therapeutic window and substantial off-target toxicity (StatPearls, 2023). Consequently, this label often serves as a placeholder in databases for substances whose precise mechanism involves pleiotropic protein interactions that cannot be attributed to a single canonical target.

Other names

Non-specific intracellular proteinsVarious cellular proteinsIntracellular protein targets (multiple)Cytoplasmic proteins

Non-specific covalent modification, cross-linking, denaturation, or oxidative damage of various intracellular protein functional groups.